Key result
ANHPI liver cancer patients linked to ~35% lower IHD risk vs Non-Hispanic White patients.
Why the study?
The specific cardiovascular disease risk profile of Asian, Native Hawaiian, and Pacific Islander liver cancer patients remains poorly understood.
Does ANHPI race/ethnicity affect the risk of incident cardiovascular disease in older liver cancer survivors compared to NHW patients?
Cohort (n=3,220)
Does ANHPI race/ethnicity affect the risk of incident cardiovascular disease in older liver cancer survivors compared to NHW patients?
While ANHPI liver cancer survivors generally have a lower risk of ischemic heart disease compared to Non-Hispanic Whites, significant heterogeneity exists, with Native Hawaiian and Pacific Islanders facing substantially higher cardiovascular risks than other Asian subgroups.
May inform ethnicity-specific CVD monitoring in liver cancer survivors; leaves open subgroup heterogeneity and prospective validation.
Cardiovascular disease (CVD) is a significant global health concern, particularly among Asian, Native Hawaiian, and Pacific Islander (ANHPI) communities that face unique health challenges. Liver cancer disproportionately affects ANHPI populations and has intricate associations with CVD risks due to shared pathophysiological mechanisms and metabolic disturbances. However, the specific CVD risk profile of ANHPI liver cancer patients remains poorly understood. Using Surveillance, Epidemiology, and End Results (SEER)-Medicare data, we identified and matched 1150 ANHPI and 2070 Non-Hispanic White (NHW) liver cancer patients diagnosed between 2000 and 2017. We used the Fine-Gray sub-distribution hazard model to estimate hazard ratios (HRs) and 95 % confidence intervals (95 % CIs) for CVD risks, including ischemic heart disease (IHD), heart failure, and stroke, among ANHPI liver cancer patients compared to NHW counterparts and among ANHPI subgroups. ANHPI liver cancer patients demonstrated a lower risk of IHD compared to NHW counterparts (HR, 0.65, 95 % CI, 0.50, 0.86), aligning with broader trends. Subgroup analysis revealed notable heterogeneity within ANHPI populations, with Southeast Asian (HR, 0.65, 95 % CI, 0.42, 1.00) and Chinese patients (HR, 0.53, 95 % CI, 0.33–0.83) exhibiting lower IHD risks compared to their NHW counterparts. However, Native Hawaiian and Pacific Islander liver cancer patients showed elevated risks of heart failure (HR, 3.16, 95 % CI, 1.35–7.39) and IHD (HR, 5.64, 95 % CI, 2.19–14.53) compared to their Chinese counterparts. Our study highlights the complexity of CVD risks among ANHPI liver cancer patients. Addressing these disparities is crucial for improving cardiovascular outcomes and reducing the burden of CVD among ANHPI liver cancer patients. • ANHPI liver cancer patients demonstrated a lower risk of ischemic heart disease (IHD) than NHW counterparts . • Subgroup analysis revealed notable heterogeneity in CVD risks within ANHPI populations, with Southeast Asian and Chinese patients . • Native Hawaiian and Pacific Islander liver cancer patients showed elevated risks of heart failure and IHD than Chinese counterparts. • Among ANHPI liver cancer survivors, risk factors for CVD include gender, age, Charlson comorbidity index, marital status, and radioembolization.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) conducted a cohort in Liver cancer (n=3,220). Asian, Native Hawaiian, and Pacific Islander (ANHPI) race/ethnicity vs. Non-Hispanic White (NHW) race/ethnicity was evaluated on Ischemic heart disease (IHD) (HR 0.65, 95% CI 0.50-0.86). Asian, Native Hawaiian, and Pacific Islander liver cancer patients had a lower risk of ischemic heart disease compared to Non-Hispanic White patients (HR 0.65; 95% CI 0.50-0.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: